Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108375. doi: 10.1016/j.mrrev.2021.108375. Epub 2021 Apr 16.
The human transcriptome contains many non-coding RNAs (ncRNAs), which play important roles in gene regulation. Long noncoding RNAs (lncRNAs) are an important class of ncRNAs with lengths between 200 and 200,000 bases. Unlike mRNA, lncRNA lacks protein-coding features, specifically, open-reading frames, and start and stop codons. LncRNAs have been reported to play a role in the pathogenesis and progression of many cancers, including breast cancer (BC), acting as tumor suppressors or oncogenes. In this review, we systematically mined the literature to identify 65 BC-related lncRNAs. We then perform an integrative bioinformatics analysis to identify 14 lncRNAs with a potential regulatory role in BC. The biological function of these 14 lncRNAs, their regulatory mechanisms, and roles in the initiation and progression of BC are discussed in this review. Additionally, we elaborate on the current and future applications of lncRNAs as diagnostic and/or therapeutic biomarkers in BC.
人类转录组包含许多非编码 RNA(ncRNA),它们在基因调控中发挥重要作用。长非编码 RNA(lncRNA)是一类重要的 ncRNA,长度在 200 到 200,000 个碱基之间。与 mRNA 不同,lncRNA 缺乏蛋白编码特征,具体来说,没有开放阅读框以及起始和终止密码子。据报道,lncRNA 在许多癌症(包括乳腺癌)的发病机制和进展中发挥作用,它们可以作为肿瘤抑制因子或癌基因。在这篇综述中,我们系统地挖掘文献,确定了 65 个与乳腺癌相关的 lncRNA。然后,我们进行综合生物信息学分析,确定了 14 个在乳腺癌中具有潜在调节作用的 lncRNA。本文讨论了这 14 个 lncRNA 的生物学功能、调控机制及其在乳腺癌发生和发展中的作用。此外,我们详细阐述了 lncRNA 作为乳腺癌诊断和/或治疗生物标志物的当前和未来应用。